Henrik Wulff

Henrik Wulff is the Executive Vice President of Chemistry, Production, Control & Supply of Products at Novo Nordisk, a leading global healthcare company focused on diabetes care and other serious chronic conditions. He was recently in the news for his announcement regarding the expansion of Novo Nordisk's manufacturing facility in Montes Claros, Brazil, which will enhance the production capacity for injectable treatments for obesity and diabetes, with an investment of R$ 6.4 billion.